Navigation Links
Vital Access Reports Live VWING Clinical Cases and SAVE Study Clinical Data Presentation at CiDA Conference
Date:10/30/2013

SALT LAKE CITY, Oct. 30, 2013 /PRNewswire/ -- Vital Access Corporation today announced that on Friday, October 25th, Dr. John Ross, MD, FACS performed live VWING Vascular Needle Guide implantation cases and Dr. William Jennings, MD, FACS presented clinical data from the pivotal U.S. SAVE study at the 2013 Controversies in Dialysis Access (CiDA) Meeting in San Francisco.

As part of the CiDA conference agenda, Dr. John Ross performed three VWING implantation cases at his surgical facilities in Orangeburg, South Carolina, two of which were broadcast live to a large audience of physicians. These three cases represent common challenges faced by patients and clinicians in achieving vascular access. The first case involved a cephalic vein arteriovenous fistula (AVF) exhibiting a short usable length, where the VWING was implanted to provide an additional cannulation site for the patient and to extend the usable length of the fistula. The second case involved a non-transposed brachiobasilic AVF where the VWING was implanted to allow cannulation of the fistula in its native position without having to transpose or elevate the vessel. The third case involved a deep radiocephalic vein AVF where the VWING was implanted to permit cannulation of the vessel in its current position and avoid a more-invasive surgical elevation procedure. In all three cases, the VWING was implanted to facilitate easier access to the fistula to allow for safe and effective dialysis treatment. Following the cases, Dr. Ross stated, "For the difficult to cannulate fistula, the standard of care may have been changed by the VWING."

Dr. William Jennings presented results from the recently completed U.S. SAVE study, an IDE pivotal trial of the VWING™ Vascular Needle Guide that supported the recent U.S. market clearance of the device. Dr. Jennings, who was a principal investigator for the SAVE study at the University of Oklahoma in Tulsa, also discussed VWING surgical techniques and cannulation practice. Dr. Jennings described his experience with the VWING, stating, "I expect the device will be an important option for vascular access surgeons. Non-usable fistulas were easily converted to a reliable vascular access quickly, using the VWING implanted in a relatively minor procedure.  Both patients and staff were very pleased with the outcomes."

Doug Smith, President and CEO of Vital Access, summarized the activities of the meeting, stating, "In addition to the live cases and scheduled SAVE study report, we were pleased to see the VWING discussed on several other occasions throughout the conference. The response during and after CiDA has been very encouraging."

About Vital Access™:

Vital Access Corporation is a privately held company located in Salt Lake City that designs and manufactures surgical and interventional technologies to improve vascular access for patients and caregivers. The VWING™ Vascular Needle Guide is commercially available in the U.S., Europe, Canada, and New Zealand. For more information, call 801-433-9390 or visit www.vital-access.com.

Contact: Doug Smith, 801-433-9390


'/>"/>
SOURCE Vital Access Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
2. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
3. inVentiv Medical Management Forms Partnership with Vital Decisions
4. New Survey Affirms Compounding Pharmacies Vital Role in Public Health
5. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
6. Frost & Sullivan: Appropriate Channel Partners Vital in the Highly Fragmented Medical Devices Distribution Market in VITSK
7. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
8. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
9. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
10. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
11. Competitive Pricing Vital in the Asia-Pacific Digital and Computed Radiography Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):